Former Moderna CMO Zaks goes back to his Israeli roots, re-emerging as Teva board directornews2021-08-30T15:26:19+00:00August 30th, 2021|Fierce Pharma|
Former Moderna CMO Zaks goes back to his Israeli roots, reemerging as Teva board directornews2021-08-30T15:26:19+00:00August 30th, 2021|Fierce Pharma|
Pharmas’ Facebook ‘Stop Hate’ ad boycott: One year later, it’s back to business as usual, ad tracker saysnews2021-08-30T15:09:10+00:00August 30th, 2021|Fierce Pharma|
Another 1M Moderna coronavirus vaccine doses halted in Japan as officials probe 2 deathsnews2021-08-30T13:28:12+00:00August 30th, 2021|Fierce Pharma|
It’s back: Eli Lilly’s COVID-19 antibody combo makes its return after 2 months on the sidelinesnews2021-08-30T13:28:07+00:00August 30th, 2021|Fierce Pharma|
Biotech co-founders admit to stealing trade secrets from Roche’s Genentech, face possible prison termsnews2021-08-30T13:20:55+00:00August 30th, 2021|Fierce Pharma|
ESC 2021: Bayer and Merck’s Verquvo stakes its claim as a complementary heart failure treatmentnews2021-08-28T05:38:23+00:00August 28th, 2021|Fierce Pharma|
ESC 2021: With ESC’s new heart failure endorsement, AstraZeneca’s blockbuster Farxiga is flying highnews2021-08-28T00:53:57+00:00August 28th, 2021|Fierce Pharma|
Roche pulls Tecentriq breast cancer nod after post-approval trial flopnews2021-08-27T18:57:25+00:00August 27th, 2021|Fierce Pharma|
ESC 2021: Bayer’s Kerendia touts outcomes data as it looks to complement J&J, AZ drugsnews2021-08-27T18:36:30+00:00August 27th, 2021|Fierce Pharma|
